Fabrizió Franchi

646 total citations
44 papers, 463 citations indexed

About

Fabrizió Franchi is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fabrizió Franchi has authored 44 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Fabrizió Franchi's work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Fabrizió Franchi is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Fabrizió Franchi collaborates with scholars based in Italy, Russia and France. Fabrizió Franchi's co-authors include Gian Pietro Molinari, Luigi Lucini, Marco Pellizzoni, Patrizia Seminara, Filippo Rossi Fanelli, C. Cangiano, Fabrizio Ceci, Maurizio Muscaritoli, A. Cascino and Giovanni Codacci-Pisanelli and has published in prestigious journals such as European Journal of Cancer, Clinical Nutrition and The American Journal of the Medical Sciences.

In The Last Decade

Fabrizió Franchi

43 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrizió Franchi Italy 9 118 102 87 82 56 44 463
Koichi Sugimoto Japan 11 63 0.5× 89 0.9× 47 0.5× 83 1.0× 61 1.1× 45 451
Takashi Kusakari Japan 17 63 0.5× 251 2.5× 75 0.9× 42 0.5× 25 0.4× 31 631
Ruhi Uyar Türkiye 13 48 0.4× 117 1.1× 27 0.3× 39 0.5× 20 0.4× 35 391
Ratna Chatterjee United Kingdom 15 67 0.6× 138 1.4× 26 0.3× 90 1.1× 18 0.3× 36 885
Bruce Wr Canada 9 158 1.3× 122 1.2× 53 0.6× 25 0.3× 30 0.5× 25 451
Tihana Žanić Grubišić Croatia 14 51 0.4× 175 1.7× 49 0.6× 122 1.5× 119 2.1× 28 488
Alba G. Blazquez Spain 13 262 2.2× 189 1.9× 39 0.4× 28 0.3× 18 0.3× 18 624
İlhan Onaran Türkiye 16 113 1.0× 296 2.9× 47 0.5× 42 0.5× 22 0.4× 55 872
Shirin Hasan United States 12 19 0.2× 127 1.2× 51 0.6× 69 0.8× 38 0.7× 34 390
Roberta M. Johnke United States 13 70 0.6× 267 2.6× 21 0.2× 51 0.6× 120 2.1× 23 571

Countries citing papers authored by Fabrizió Franchi

Since Specialization
Citations

This map shows the geographic impact of Fabrizió Franchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizió Franchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizió Franchi more than expected).

Fields of papers citing papers by Fabrizió Franchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizió Franchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizió Franchi. The network helps show where Fabrizió Franchi may publish in the future.

Co-authorship network of co-authors of Fabrizió Franchi

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizió Franchi. A scholar is included among the top collaborators of Fabrizió Franchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizió Franchi. Fabrizió Franchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franchi, Fabrizió, et al.. (2008). Darbepoetin in the control of cancer-related anaemia. Clinical and Experimental Medicine. 8(4). 225–227. 1 indexed citations
2.
Franchi, Fabrizió, et al.. (2007). Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. European Journal of Cancer Care. 16(3). 258–262. 7 indexed citations
3.
Seminara, Patrizia, et al.. (2007). Mitomycin C and Etoposide in Advanced Colorectal Carcinoma. Chemotherapy. 53(3). 218–225. 6 indexed citations
4.
Franchi, Fabrizió, et al.. (2003). Favorable Toxicity Profile of Raltitrexed in Elderly Patients Treated for Colorectal Cancer: A Case Series. Gerontology. 49(5). 324–327. 5 indexed citations
5.
Seminara, Patrizia, Fabrizió Franchi, Claudio Pioli, et al.. (2001). Activity of a Nitroxylated Analog of Daunorubicin, Ruboxyl, in B-Lymphoproliferative Disorders. Acta Haematologica. 105(2). 77–82. 2 indexed citations
6.
Seminara, Patrizia, et al.. (2001). In vitro Models of a Three-Drug Regimen (Epirubicin, Cisplatin and Fluorouracil) for the Treatment of Colorectal Cancer. Chemotherapy. 47(6). 430–437. 3 indexed citations
7.
Isgrò, Antonella, Ivano Mezzaroma, Alessandro Aiuti, et al.. (2000). Recovery of Hematopoietic Activity in Bone Marrow from Human Immunodeficiency Virus Type 1-Infected Patients during Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 16(15). 1471–1479. 36 indexed citations
8.
Codacci-Pisanelli, Giovanni, et al.. (1999). Activity of Ruboxyl, a Nitroxyl Derivative of Daunorubicin, on Experimental Models of Colorectal Cancer Metastases. Tumor Biology. 20(5). 270–276. 4 indexed citations
9.
Giorgio, Angelo Di, et al.. (1997). The Role of Hypoxic Stop-Flow Perfusion and High Dose Chemotherapy in the Treatment of Regionally Advanced Colorectal Cancer. Journal of Chemotherapy. 9(6). 436–441. 1 indexed citations
10.
Codacci-Pisanelli, Giovanni, et al.. (1997). High-dose chemotherapy with bone marrow transplantation for advanced colorectal cancer. International Journal of Oncology. 11(1). 25–9. 1 indexed citations
11.
Codacci-Pisanelli, Giovanni, C.L. van der Wilt, Herbert M. Pinedo, et al.. (1995). Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice. European Journal of Cancer. 31(9). 1517–1525. 19 indexed citations
12.
Franchi, Fabrizió, Filippo Rossi Fanelli, Patrizia Seminara, et al.. (1991). Cell Kinetics of Gastrointestinal Tumors After Different Nutritional Regimens. Journal of Clinical Gastroenterology. 13(3). 313–315. 7 indexed citations
13.
Franchi, Fabrizió, Carlo Barone, Enrico Ricevuto, et al.. (1991). 5-Fluorouracil (FU) with folinic acid (FA) and mitomycin c (MMC) in the adjuvant treatment of colorectal carcinoma. part i. evaluation of toxicity. Medical Oncology and Tumor Pharmacotherapy. 8(2). 69–73. 4 indexed citations
14.
Cascino, A., C. Cangiano, Fabrizio Ceci, et al.. (1988). Plasma amino-acids in human cancer: the individual role of tumour, malnutrition and glucose tolerance. Clinical Nutrition. 7(4). 213–218. 8 indexed citations
15.
Franchi, Fabrizió, et al.. (1987). A new anthracycline regimen for prolymphocytic leukemia? Study of a case report with flow cytometric implications. Leukemia Research. 11(10). 947–949. 1 indexed citations
16.
Franchi, Fabrizió, et al.. (1986). The non-producer plasma cell myeloma. Annals of Hematology. 52(5). 281–287. 6 indexed citations
17.
Franchi, Fabrizió, et al.. (1984). Hypereosinophilic Syndrome and Plasmocytoma. Acta Haematologica. 72(1). 14–20. 5 indexed citations
18.
Franchi, Fabrizió, Paolo Seminara, & Stefano Calvieri. (1983). Interdigitating Reticulum Cell and Lymphoproliferative Disease: Possible Correlations between Skin and Thymus-Dependent Lymphocyte System Revisited. Acta Haematologica. 70(3). 154–157. 1 indexed citations
19.
Franchi, Fabrizió, et al.. (1980). [Clinico-immunological studies of 32 cases of bone tumors].. PubMed. 71(25). 1815–22. 1 indexed citations
20.
Calvani, Menotti, et al.. (1979). [Thymus dysplasia with circulating T-lymphocytes but not responsive to mitogen. Post-transfusional fatal graft-versus-host disease].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(21). 1555–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Sugimoto Breakdown of academic impact, for papers by Takashi Kusakari Breakdown of academic impact, for papers by Ruhi Uyar Breakdown of academic impact, for papers by Ratna Chatterjee Breakdown of academic impact, for papers by Bruce Wr Breakdown of academic impact, for papers by Tihana Žanić Grubišić Breakdown of academic impact, for papers by Alba G. Blazquez Breakdown of academic impact, for papers by İlhan Onaran Breakdown of academic impact, for papers by Shirin Hasan Breakdown of academic impact, for papers by Roberta M. Johnke
Rankless by CCL
2026